These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26190360)

  • 41. Zoledronate induces osteonecrosis of the jaw in sheep.
    Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
    Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F
    J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mate tea (Ilex paraguariensis) improves bone formation in the alveolar socket healing after tooth extraction in rats.
    Brasilino MDS; Stringhetta-Garcia CT; Pereira CS; Pereira AAF; Stringhetta K; Leopoldino AM; Crivelini MM; Ervolino E; Dornelles RCM; de Melo Stevanato Nakamune AC; Chaves-Neto AH
    Clin Oral Investig; 2018 Apr; 22(3):1449-1461. PubMed ID: 29032403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The beneficial effect of intravenous zoledronic acid therapy following an acute stroke in rats.
    Lee JI; Kim HW; Rhee WI; Park JH; Lim SH; Im S; Ko YJ
    Bone; 2006 Aug; 39(2):377-82. PubMed ID: 16580897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Marino KL; Zakhary I; Abdelsayed RA; Carter JA; O'Neill JC; Khashaba RM; Elsalanty M; Stevens MR; Borke JL
    J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy.
    Vescovi P; Giovannacci I; Merigo E; Meleti M; Manfredi M; Fornaini C; Nammour S
    J Craniofac Surg; 2015 May; 26(3):696-9. PubMed ID: 25915674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinctive tooth-extraction socket healing: bisphosphonate versus parathyroid hormone therapy.
    Kuroshima S; Mecano RB; Tanoue R; Koi K; Yamashita J
    J Periodontol; 2014 Jan; 85(1):24-33. PubMed ID: 23688101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ozonated oil effect for prevention of medication-related osteonecrosis of the jaw (MRONJ) in rats undergoing zoledronic acid therapy.
    Monteiro CGJ; Vieira EM; Emerick C; Azevedo RS; Pascoal VAB; Homsi N; Lins RX
    Clin Oral Investig; 2021 Dec; 25(12):6653-6659. PubMed ID: 33895916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
    Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
    BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw.
    Adachi N; Ayukawa Y; Yasunami N; Furuhashi A; Imai M; Sanda K; Atsuta I; Koyano K
    Sci Rep; 2020 Mar; 10(1):5620. PubMed ID: 32221325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
    Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP
    Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws.
    López-Jornet P; Camacho-Alonso F; Martínez-Canovas A; Molina-Miñano F; Gómez-García F; Vicente-Ortega V
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2488-93. PubMed ID: 21798645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ellagic Acid Increases Osteocalcin and Alkaline Phosphatase After Tooth Extraction in Nicotinic-Treated Rats.
    Al-Obaidi MM; Al-Bayaty FH; Al Batran R; Ibrahim OE; Daher AM
    Curr Pharm Des; 2016; 22(16):2403-10. PubMed ID: 27139374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of Medication-Related Osteonecrosis of the Jaw After Extraction of Teeth With Experimental Periapical Disease.
    Hadaya D; Soundia A; Gkouveris I; Dry SM; Aghaloo TL; Tetradis S
    J Oral Maxillofac Surg; 2019 Jan; 77(1):71-86. PubMed ID: 30218655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the Effect of Resveratrol on the Healing of Extraction Sockets in Cyclosporine A-Treated Rats.
    Ozcan-Kucuk A; Alan H; Gul M; Yolcu U
    J Oral Maxillofac Surg; 2018 Jul; 76(7):1404-1413. PubMed ID: 29605535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.
    Curra C; Cardoso CL; Ferreira O; Curi MM; Matsumoto MA; Cavenago BC; Santos PL; Santiago JF
    Acta Cir Bras; 2016 May; 31(5):308-13. PubMed ID: 27275851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats.
    Dayisoylu EH; Üngör C; Tosun E; Ersöz S; Kadioglu Duman M; Taskesen F; Senel FÇ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):329-34. PubMed ID: 24368141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.